PlainPharmaWatch

CMS Open Payments · Program Year 2024

Ferring Pharmaceuticals SA Rep Office Middle East

Ferring Pharmaceuticals SA Rep Office Middle East reported $313.53 across General Payments, Research, and Ownership to 3 physicians and teaching hospitals across 3 transactions.

$313.53
All-tracks total
3
Transactions
3
Recipients
#1888
of 1,925 companies

Ferring Pharmaceuticals SA Rep Office Middle East reported $313.53 across all CMS Open Payments tracks (General + Research + Ownership) to 3 physicians and teaching hospitals in Program Year 2024 - ranking #1888 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $313.53, averaging $104.51 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer ferring-pharmaceuticals-sa-rep-office-middle-east Ferring Pharmaceuticals SA Rep Office Middle East

$313.53 · #1888/1,925 · 0.0% industry · PY2024

  • TOT $313.53
  • RANK #1888
  • SHARE 0.0%
  • TXN 3
  • RCP 3
  • CAT 2
  • GEN $313.53
  • TOP1 100.0%
  • PY 2024

Nearest volume peer: Quest Medical Inc. ($314.09)

Ricoh USA, Inc.$336.00Owens & Minor Distribution, …$316.70Quest Medical Inc.$314.09Ferring Pharmaceuticals SA R…$313.53DTE Oregon, Inc.$304.57
All-tracks payment totals near Ferring Pharmaceuticals SA Rep Office Middle East (CMS Open Payments PY2024)

Ferring Pharmaceuticals SA Rep Office Middle East sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Ferring Pharmaceuticals SA Rep Office Middle East

Ferring Pharmaceuticals SA Rep Office Middle East ranks #1888 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $313.53 across 3 transactions to 3 physicians and teaching hospitals - $104.51 per transaction and $104.51 per recipient on average.

Of the 2 general-payment categories charted below, "Food and Beverage" is the largest at $167.58 across 2 transactions, 53.4% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Food and Beverage" leads Ferring Pharmaceuticals SA Rep Office Middle East's 2-category general-payment breakdown at $167.58, 53.4% of the reported total.

How Ferring Pharmaceuticals SA Rep Office Middle East divides its payments

How the reported total splits across payment categories

1. Food and Beverage$167.582. Travel and Lodging$145.95
Payment Type Amount Transactions
Food and Beverage $167.58 2
Travel and Lodging $145.95 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $313.53 (100.0%) of $313.53 in this company's General Payments records across 1 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Ferring Pharmaceuticals SA Rep Office Middle East

The five named recipients with the highest reported General Payments from this company

Michael Fakih$313.53
  1. 1

    Michael Fakih

    $313.53 across 3 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Ferring Pharmaceuticals SA Rep Office Middle East's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Ferring Pharmaceuticals SA Rep Office Middle East.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Ferring Pharmaceuticals SA Rep Office Middle East.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Ferring Pharmaceuticals SA Rep Office Middle East's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.